These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1679278)

  • 1. Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: a comparative study.
    Louis DN; Edgerton S; Thor AD; Hedley-Whyte ET
    Acta Neuropathol; 1991; 81(6):675-9. PubMed ID: 1679278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferating cell nuclear antigen expression in central nervous system neoplasms.
    Allegranza A; Girlando S; Arrigoni GL; Veronese S; Mauri FA; Gambacorta M; Pollo B; Dalla Palma P; Barbareschi M
    Virchows Arch A Pathol Anat Histopathol; 1991; 419(5):417-23. PubMed ID: 1721471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens.
    Khoshyomn S; Maier H; Morimura T; Kitz K; Budka H
    Acta Neuropathol; 1993; 86(6):582-9. PubMed ID: 7906072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferating cell nuclear antigen (PCNA): expression in samples of human astrocytic gliomas.
    Revesz T; Alsanjari N; Darling JL; Scaravilli F; Lane DP; Thomas DG
    Neuropathol Appl Neurobiol; 1993 Apr; 19(2):152-8. PubMed ID: 8100356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical detection of cell proliferation-related antigens in cytologic smears of human malignant neoplasms using PC10, reactive with proliferating cell nuclear antigen, and Ki-67. A comparative study.
    Pelosi G; Bresaola E; Manfrin E; Rodella S; Schiavon I; Iannucci A
    Arch Pathol Lab Med; 1994 May; 118(5):510-6. PubMed ID: 7910728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferating cell nuclear antigen (PCNA) and Ki-67 immunopositivity in human astrocytic tumours.
    Kordek R; Biernat W; Alwasiak J; Liberski PP
    Acta Neurochir (Wien); 1996; 138(5):509-12; discussion 513. PubMed ID: 8800324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCNA and Ki-67 in central nervous system tumors: correlation with the histological type and grade.
    Kayaselçuk F; Zorludemir S; Gümürdühü D; Zeren H; Erman T
    J Neurooncol; 2002 Apr; 57(2):115-21. PubMed ID: 12125971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of proliferative grade in glial neoplasms using antibodies to the Ki-67 defined antigen and PCNA in formalin fixed, deparaffinized tissues.
    Hoyt JW; Gown AM; Kim DK; Berger MS
    J Neurooncol; 1995; 24(2):163-9. PubMed ID: 7562003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.
    Onda K; Davis RL; Shibuya M; Wilson CB; Hoshino T
    Cancer; 1994 Oct; 74(7):1921-6. PubMed ID: 7521787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
    Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E
    Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between Ki-67 labeling and mitotic index in gliomas and meningiomas: demonstration of the variability of the intermitotic cycle time.
    Schröder R; Bien K; Kott R; Meyers I; Vössing R
    Acta Neuropathol; 1991; 82(5):389-94. PubMed ID: 1767633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferating cell nuclear antigen immunoreactivity in human central nervous system neoplasms.
    Karamitopoulou E; Perentes E; Melachrinou M; Maraziotis T
    Acta Neuropathol; 1993; 85(3):316-22. PubMed ID: 7681617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of p53-protein expression and the PCNA and Ki-67 proliferating cell indices in human astrocytomas.
    Kordek R; Biernat W; Debiec-Rychter M; Alwasiak J; Liberski PP
    Pathol Res Pract; 1996 Mar; 192(3):205-9. PubMed ID: 8739466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of cell proliferation in gastric carcinoma: comparative analysis of Ki-67 and proliferative cell nuclear antigen (PCNA).
    Rosa JC; Mendes R; Filipe MI; Morris RW
    Histochem J; 1992 Feb; 24(2):93-101. PubMed ID: 1349600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferating cell nuclear antigen and Ki-67 immunohistochemistry of oligodendrogliomas with special reference to prognosis.
    Heegaard S; Sommer HM; Broholm H; Broendstrup O
    Cancer; 1995 Nov; 76(10):1809-13. PubMed ID: 8625052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of PCNA, Ki67, AgNOR and p53 expression in brain glial tumors].
    Berny W; Weiser A; Markowska-Woyciechowska A; Jarmundowicz W; Zub W; Załuski R
    Neurol Neurochir Pol; 2004; 38(6):457-63. PubMed ID: 15654669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PCNA/cyclin expression in transitional cell carcinomas of the human bladder: its correlation with Ki-67 and epidermal growth factor receptor immunostainings.
    Serio G
    Pathologica; 1994 Apr; 86(2):161-6. PubMed ID: 7936759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic values of proliferating cell nuclear antigen (PCNA) and Ki-67 for radiotherapy of oesophageal squamous cell carcinomas.
    Okuno Y; Nishimura Y; Kashu I; Ono K; Hiraoka M
    Br J Cancer; 1999 May; 80(3-4):387-95. PubMed ID: 10408843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling.
    Kamel OW; LeBrun DP; Davis RE; Berry GJ; Warnke RA
    Am J Pathol; 1991 Jun; 138(6):1471-7. PubMed ID: 1675840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection of proliferative cells.
    Mokrý J; Nĕmecek S
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.